All News

Prize Awarded to App that Helps Patients with Cancer Monitor Symptoms and ‘Take Agency Back’

September 13th 2022

This article is sponsored Astellas Pharma US, Inc.

FDA’s Enhertu Approval is ‘Even More Important’ for a Group of Patients With Difficult to Treat Lung Cancer, Says Expert

September 13th 2022

An expert discusses what patients need to know about the recent FDA approval of Enhertu for HER2-mutant non-small cell lung cancer, an aggressive subtype of the disease.

Tumor-Infiltrating Lymphocyte Decreases Death Risk in Unresectable Skin Cancer

September 13th 2022

The use of a tumor-infiltrating lymphocyte therapy led to better outcomes than treatment with Yervoy in patients with unresectable, treatment-refractory stage 3/4 melanoma, a type of skin cancer, study results showed.

Finding the Courage to Look at Family Cancer History

September 12th 2022

As National Previvor Day approaches, I’m getting back on my soapbox to discuss genetic testing and family histories of cancer. After all, these discussions could save lives.

Adding Keytruda to a Combination of Abiraterone Acetate Plus Prednisone Continues to Demonstrate Anti-Tumor Activity in a Group of Patients With Prostate Cancer

September 12th 2022

With nearly one-year of additional follow-up, adding Keytruda to the combination of abiraterone acetate and the steroid prednisone shows continued benefit in men with metastatic castration-resistant prostate cancer.

Cancer Made Me Feel Invisible as I Was the Sickest Girl in Every Room

September 12th 2022

When going through treatment for advanced-stage lung cancer, people would often talk to me like I was a child, or ignore me altogether and speak to my husband.

Adding Cabometyx to Immunotherapy Combination Improves Outcomes for Advanced Kidney Cancer

September 12th 2022

The addition of Cabometyx to the current standard-of-care frontline regimen of Opdivo plus Yervoy improved progression-free survival outcomes in patients with advanced kidney cancer.

Lenvima Plus Keytruda Bests Chemotherapy for Advanced Endometrial Cancer

September 12th 2022

Lenvima plus Keytruda improved survival outcomes for patients with pretreated advanced endometrial cancer, according to recent clinical trial data.

CAR-T Cell Therapy Shows Promise in Relapsed/Refractory Solid Cancers

September 11th 2022

BNT211-01, a novel CAR-T cell therapy, was efficacious in treating patients with CLDN6-positive, relapsed/refractory solid cancers, according to a small clinical trial.

Trodelvy May Fulfill Unmet Need for Subset of Patients With Metastatic Breast Cancer

September 10th 2022

Compared to physician’s choice of treatment, Trodelvy improved survival and quality of life in pretreated patients with HR positive/HER2 negative metastatic breast cancer.

Adding the Novel Drug Oleclumab to Imfinzi and Chemotherapy Fails to Improve TNBC Outcomes

September 9th 2022

Adding the novel drug oleclumab to Imfinzi and chemotherapy for the frontline treatment of advanced triple-negative breast cancer did not improve clinical outcomes, according to recent study findings.

Rubraca Staves Off Disease Progression Better Than Chemotherapy in BRCA-Mutant Relapsed Ovarian Cancer, Research Shows

September 9th 2022

Rubraca improved progression-free survival in patients with BRCA1/2-mutant, platinum-sensitive, relapsed ovarian cancer, according to findings from the ARIEL4 clinical trial.

Bravery Versus Courage When Faced with Cancer

September 9th 2022

When my daughter first started cancer treatment, she was brave, but after she understood how difficult it was, she was courageous in continuing.

Jane Fonda Provides a Cancer Update, Old News Clipping Helps Patient With Leukemia Benefit from the Sept. 11 Victim Fund and More

September 9th 2022

From actress Jane Fonda giving an update on her cancer, to a patient with leukemia proving he was at the Sept. 11 attacks in New York City with an old newspaper clipping, here’s what’s happening in the cancer space this week.

FDA Issues Statement on New Cases of Rare Breast Implant-Related Cancers

September 9th 2022

The Food and Drug Administration issued a statement about the incidence of new cases of rare cancers that have occurred in the scar tissue around breast implants.

Phase 2 Trial to Study Novel Drug in Pretreated Solid Tumors

September 8th 2022

The first patient was treated in a phase 2 trial assessing the safety and efficacy of navicixizumab, with or without chemotherapy, in colorectal, gastric, ovarian and breast cancer.

20 Years of Cancer Survivorship Care Plans: From a Piece of Paper to a Process

September 8th 2022

The time after cancer treatment can be overwhelming, but great progress in survivorship care plans over the past two decades has provided better guidance for an easier transition.

Who Will Be the Next Celebrity Face of Cancer?

September 8th 2022

When celebrities are diagnosed with cancer, they wield great power to bring awareness to the disease but being in the public eye must be extremely challenging, especially when facing a personal health crisis.

Cancer Survivors Can Fall in Love With New Recipes

September 8th 2022

With a new season comes a new rotation of vegetables that are at their peak — making it the perfect time to incorporate their nutritional value into meals!

Overcoming the Fear of Cancer Recurrence

September 8th 2022

For many cancer survivors, a dark cloud hangs over them after treatment ends, as they fear their disease coming back.

5 Ways I Turn Anger Into Cancer Advocacy and Get Busy Livin’

September 7th 2022

I’ve channeled my cancer-related anger into advocacy, and made a “living list” of things I want to accomplish.

Awareness of Risk for Heart Disease May Mitigate Underdiagnosis in Childhood Cancer Survivors

September 7th 2022

It is important for cancer survivors to know their risk of developing heart disease, even years after treatment has ended, as they may be underdiagnosed or undertreated for them.

My Treasured Box of Cancer Greetings

September 7th 2022

I recently came across a shoebox full of cards sent to me after I was diagnosed with cancer. The love expressed by others was uplifting to me.

Advocating for Reproductive Health in Cancer Survivorship

September 7th 2022

Some cancer survivors might not have had the opportunity to preserve fertility prior to cancer treatment, leaving them unable to family plan.

Trodelvy Lengthens Time to Disease Progression in Metastatic Breast Cancer

September 7th 2022

Trodelvy bested chemotherapy for progression-free survival in patients with HR-positive, HER2-negative metastatic breast cancer.

The Journey to a Healthy Lifestyle After Cancer

September 6th 2022

One cancer survivor describes how making healthier choices in diet and exercise has improved her quality of life and relationship with others.

Getting Out of the Woods: Strategies to Cope With Fear of Cancer Recurrence

September 6th 2022

Cognitive therapy, teletherapy, journaling and taking up other daily activities may help cancer survivors overcome their fear of recurrence.

Cancer Made Me Appreciate the Small Things in Life

September 6th 2022

There’s a flip side to the trauma of cancer — a better appreciation of the small things in everyday life.

Addressing Health Concerns, Increasing Exercise Can Help Patients Prepare for Kidney Cancer Surgery

September 6th 2022

Preparing for kidney cancer surgery encapsulates a full-body approach, which can help improve outcomes after the procedure.

I Found My Voice in My Cancer Care and Refused Decisions I Was Uncomfortable With

September 6th 2022

After I was diagnosed with anal cancer, doctors wanted me to get an colostomy bag, but I refused. Later on, I had to voice my concern about a drug that could improve my chances for survival.